These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32811625)

  • 21. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.
    Lee DC; Schlienz NJ; Peters EN; Dworkin RH; Turk DC; Strain EC; Vandrey R
    Drug Alcohol Depend; 2019 Jan; 194():500-517. PubMed ID: 30530238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial functioning among regular cannabis users with and without cannabis use disorder.
    Foster KT; Arterberry BJ; Iacono WG; McGue M; Hicks BM
    Psychol Med; 2018 Aug; 48(11):1853-1861. PubMed ID: 29173210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley J
    Child Adolesc Psychiatr Clin N Am; 2023 Jan; 32(1):141-155. PubMed ID: 36410901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.
    Cornelius JR; Salloum IM; Ferrell R; Douaihy AB; Hayes J; Kirisci L; Horner M; Daley DC
    Int J Med Biol Front; 2012; 18(6):399-411. PubMed ID: 25328373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men.
    Womack SR; Shaw DS; Weaver CM; Forbes EE
    J Stud Alcohol Drugs; 2016 Mar; 77(2):287-97. PubMed ID: 26997187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis use disorder trajectories and their prospective predictors in a large population-based sample of young Swiss men.
    Marmet S; Studer J; Wicki M; Gmel G
    Addiction; 2021 Mar; 116(3):560-570. PubMed ID: 32621560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys.
    Onaemo VN; Fawehinmi TO; D'Arcy C
    J Affect Disord; 2021 Feb; 281():467-475. PubMed ID: 33360749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis and Depression: A Twin Model Approach to Co-morbidity.
    Smolkina M; Morley KI; Rijsdijk F; Agrawal A; Bergin JE; Nelson EC; Statham D; Martin NG; Lynskey MT
    Behav Genet; 2017 Jul; 47(4):394-404. PubMed ID: 28466235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents.
    Wittchen HU; Fröhlich C; Behrendt S; Günther A; Rehm J; Zimmermann P; Lieb R; Perkonigg A
    Drug Alcohol Depend; 2007 Apr; 88 Suppl 1():S60-70. PubMed ID: 17257779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relations between anxious, depressive and borderline symptomatology and frequency of cannabis use and dependence].
    Chabrol H; Duconge E; Roura C; Casas C
    Encephale; 2004; 30(2):141-6. PubMed ID: 15107716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD.
    Metrik J; Jackson K; Bassett SS; Zvolensky MJ; Seal K; Borsari B
    Psychol Addict Behav; 2016 Nov; 30(7):743-754. PubMed ID: 27786514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS.
    Moitra E; Anderson BJ; Stein MD
    Depress Anxiety; 2016 Apr; 33(4):332-8. PubMed ID: 26636547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
    Sherman BJ; Sofis MJ; Borodovsky JT; Gray KM; McRae-Clark AL; Budney AJ
    Psychol Addict Behav; 2022 Aug; 36(5):505-514. PubMed ID: 34197135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
    Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
    Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The social context of cannabis use: relationship to cannabis use disorders and depressive symptoms among college students.
    Beck KH; Caldeira KM; Vincent KB; O'Grady KE; Wish ED; Arria AM
    Addict Behav; 2009 Sep; 34(9):764-8. PubMed ID: 19497678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of cardiac arrhythmias in cannabis use disorder related hospitalizations in teenagers from 2003 to 2016 in the United States.
    Umapathi KK; Thavamani A; Dhanpalreddy H; Nguyen HH
    Europace; 2021 Aug; 23(8):1302-1309. PubMed ID: 33723583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use.
    Buckner JD; Morris PE; Zvolensky MJ
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):272-278. PubMed ID: 34264732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary Outcomes of a Computerized CBT/MET Intervention for Depressed Cannabis Users in Psychiatry Care.
    Glasner S; Kay-Lambkin F; Budney AJ; Gitlin M; Kagan B; Chokron-Garneau H; Ang A; Venegas A
    Cannabis; 2018; 1(2):36-47. PubMed ID: 31840135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moral injury and cannabis use disorder among Israeli combat veterans: The role of depression and perceived social support.
    Ashwal-Malka A; Tal-Kishner K; Feingold D
    Addict Behav; 2022 Jan; 124():107114. PubMed ID: 34543870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.
    Kuhns L; Kroon E; Colyer-Patel K; Cousijn J
    Psychopharmacology (Berl); 2022 May; 239(5):1231-1249. PubMed ID: 34741634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.